| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $47.3M | +34.3% | +50.0% |
| Cost of Revenue | $36.1M | +36.7% | +48.0% |
| Gross Profit | $11.1M | +27.0% | +56.6% |
| R&D Expense | $80K | +45.5% | -48.4% |
| SG&A Expense | $10.2M | +45.9% | +60.0% |
| Operating Income | $823K | -51.6% | +46.2% |
| Income Tax | $186K | -49.5% | +45.3% |
| Net Income | $540K | -57.7% | +31.7% |
| EPS (Basic) | $0.01 | -66.7% | +0.0% |
| EPS (Diluted) | $0.01 | -66.7% | +0.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.1M | +92.5% | +93.9% |
| Accounts Receivable | $11.0M | +63.9% | +28.9% |
| Inventory | $10.4M | +61.0% | +224.8% |
| Current Assets | $41.0M | +74.8% | +86.2% |
| Total Assets | $84.0M | +64.0% | +75.4% |
| Current Liabilities | $22.1M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.2M | — | — |
| Capital Expenditures | $1.2M | — | — |
| Investing Cash Flow | -$18.7M | — | — |
| Financing Cash Flow | $21.5M | — | — |
| Free Cash Flow | $7.0M | — | — |
| +17.5% |
| Total Liabilities | $34.4M | +59.1% | +38.3% |
| Stockholders' Equity | $49.6M | +67.6% | +115.7% |